Filing Details

Accession Number:
0001161697-21-000393
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-19 17:07:54
Reporting Period:
2021-08-17
Accepted Time:
2021-08-19 17:07:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1369568 Catalyst Pharmaceuticals Inc. CPRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1402652 Alicia Grande 355 Alhambra Circle, Suite 801
Coral Gables FL 33134
Vp, Treasurer And Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Per Share Acquisiton 2021-08-17 100,000 $3.12 507,441 No 4 M Direct
Common Stock, Par Value $0.001 Per Share Disposition 2021-08-17 100,000 $5.67 407,441 No 4 S Direct
Common Stock, Par Value $0.001 Per Share Acquisiton 2021-08-18 70,000 $3.12 477,441 No 4 M Direct
Common Stock, Par Value $0.001 Per Share Disposition 2021-08-18 13,000 $5.68 464,441 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options to purchase common stock Disposition 2021-08-17 100,000 $0.00 100,000 $3.12
Common Stock Options to purchase common stock Disposition 2021-08-18 70,000 $0.00 70,000 $3.12
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,391,334 2021-08-28 No 4 M Direct
1,321,334 2021-08-28 No 4 M Direct
Footnotes
  1. Shares were sold in various lots from $5.62 to $5.725 per share. The listed sale price represents a weightedaverage price for the shares sold.
  2. Shares were sold in various lots from $5.65 to $5.785 per share. The listed sale price represents a weighted average price for the shares sold.
  3. Shares were sold to cover exercise price of options and tax withholding requirements.
  4. Options vested in three annual tranches beginning on August 28, 2015.